Stay updated on METIMMOX Clinical Trial: OXaliplatin in Colorectal METastasis
Sign up to get notified when there's something new on the METIMMOX Clinical Trial: OXaliplatin in Colorectal METastasis page.

Latest updates to the METIMMOX Clinical Trial: OXaliplatin in Colorectal METastasis page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedMinor content changes: added Revision: v3.3.3 and removed the HHS Vulnerability Disclosure link along with Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedPublications section now notes that publications are automatically filled from PubMed and may not all relate to the study; the revision tag was updated to v3.3.2, replacing v3.2.0.SummaryDifference0.1%

- Check44 days agoChange DetectedThe bottom government operating status notice has been removed. All other study details and navigation remain unchanged.SummaryDifference0.3%

- Check59 days agoChange DetectedPublications section added with related articles and authors. Enrollment and study record dates updated to reflect recent activity for METIMMOX.SummaryDifference0.4%

- Check87 days agoChange DetectedAdded a prominent operating-status notice and version bump to v3.2.0; removed reference to v3.1.0. The page now informs users about potential processing delays and where to check for status.SummaryDifference2%

- Check94 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.SummaryDifference0.0%

Stay in the know with updates to METIMMOX Clinical Trial: OXaliplatin in Colorectal METastasis
Enter your email address, and we'll notify you when there's something new on the METIMMOX Clinical Trial: OXaliplatin in Colorectal METastasis page.